Here Are the Facts You Need to Understand WBA

By Naomi Wentworth • Friday, November 11 15:31 • Permanent Link

With gains of 7.8%, Walgreens Boots Alliance was one of the winners on Wall Street today. Its shares are now trading at $41.48 and have logged a 1.0% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

Walgreens Boots Alliance has moved -22.3% over the last year, and the S&P 500 logged a change of -15.5%
WBA has an average analyst rating of hold and is 5.72% away from its mean target price of $39.24 per share
Its trailing earnings per share (Eps) is $5.01
Walgreens Boots Alliance has a trailing 12 month Price to Earnings (P/E) ratio of 8.3 while the S&P 500 average is 15.97
Its forward earnings per share (Eps) is $4.78 and its forward P/E ratio is 8.7
The company has a Price to Book (P/B) ratio of 1.4 in contrast to the S&P 500's average ratio of 2.95
Walgreens Boots Alliance is part of the Healthcare sector, which has an average P/E ratio of 13.21 and an average P/B of 4.07
The company has a free cash flow of $3,260,750,080.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides health and wellness, and specialty and home delivery pharmacy services. As of August 31, 2022, this segment operated 8,886 retail stores under the Walgreens and Duane Reade brands in the United States; and 3 specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2022, this segment operated 3,989 retail stores under the Boots, Benavides, and Ahumada brands in the United Kingdom, Thailand, the Republic of Ireland, and Chile; and 543 optical practices, including 160 on a franchise basis. The U.S. Healthcare segment provides value-based primary care services; post-acute and home care management services; and clinical healthcare services. It also operates as a specialty pharmacy integrator and accelerator for hospitals. As of August 31, 2022, this segment operated 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

At Market Interference, we believe in giving retail investors access to timely and accurate data to help inform their investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.